New Device Approved for Screening Dense Breasts

Article

The FDA recently announced that an ultrasound (U/S) device for breast cancer screening– the somo-v ABUS–has been approved for use in women with dense breasts.

The FDA recently announced that an ultrasound (U/S) device for breast cancer screening– the somo-v ABUS–has been approved for use in women with dense breasts.

Made by U-Systems of Sunnyvale, Calif, the product is to be used along with standard mammography in women with a negative mammogram and no breast cancer symptoms. It has a specially shaped transducer that automatically scans the entire breast in about 1 minute, producing several images for review, according to the FDA.

In a trial conducted by U-Systems, radiologists examined mammograms from 200 asymptomatic women with dense breasts, with and without supplementary U/S images from the somo-v ABUS device. Results indicated that use of the U/S images increased breast cancer detection by about 30%. Approximately 4% of results in the trial were false-positives.

Because previous breast intervention such as surgery or biopsy might alter the appearance of breast tissue on U/S, the agency said that women who had previously had such interventions would not generally be eligible for screening with the device.

For clinicians and technologists who plan to use the device, the FDA will require that U-Systems conduct training. The company must also distribute a manual that describes quality control tests that users should perform regularly.

Read other articles in this issue of Special Delivery.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Ousseny Zerbo, PhD, highlights benefits of influenza vaccination during pregnancy | Image Credit: divisionofresearch.kaiserpermanente.org.
Michael Ussher, PhD, highlights the benefits of vaping over smoking in pregnancy | Image Credit: sgul.ac.uk.
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Related Content
© 2025 MJH Life Sciences

All rights reserved.